Introduction
ST-elevation acute coronary syndrome (STE-ACS) is typically caused by acute thrombotic occlusion of a coronary artery due to atherosclerotic plaque erosion or rupture. However, a significant proportion of patients with STE-ACS have no angiographic evidence of obstructive coronary artery disease (CAD). [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] STE-ACS patients without obstructive CAD make up a heterogeneous group, including several different cardiac and non-cardiac conditions. 3, 6, 8, 9, 11, 12, [14] [15] [16] In general, patients presenting with ACS without obstructive CAD have a better survival compared with patients with obstructive CAD. [17] [18] [19] However, survival is likely to vary substantially among the patients without obstructive CAD depending on the underlying cause of disease and risk factors. ST-elevation on presentation has been associated with a higher mortality. 1, 7 Yet, there is currently little knowledge on the prognosis for the subgroup of STE-ACS patients without obstructive CAD. Although a few studies have compared survival rates in STE-ACS patients with and without obstructive CAD, these are limited by small sample sizes and very low event rates. 2, 3, 5, 8, 10, 11 In particular, data on long-term mortality are sparse and causes of death have not been studied in detail. Additionally, there are no data on survival for STE-ACS patients without obstructive CAD compared with people in the general population.
To increase the knowledge on the prognosis in STE-ACS patients without obstructive CAD, we aimed to (i) study short-and longterm survival and (ii) causes of death in a large group of unselected STE-ACS patients with and without obstructive CAD, and (iii) compare survival in these patients with survival of people in the general population.
Methods

Study setting
The Heart Centre, Rigshospitalet, Copenhagen University Hospital in Copenhagen, Denmark is a tertiary large-volume cardiac invasive centre [>1000 primary percutaneous coronary intervention (PCI) procedures yearly]. The centre covers the entire region of eastern Denmark, with approximately 2 250 000 inhabitants. Everyone in the region is able to reach the cardiac invasive centre within 2 h by ambulance or helicopter transport. Accordingly, primary PCI is the recommended treatment strategy for ST-elevation myocardial infarction (STEMI) and fibrinolysis is very rarely used. By the use of telemedicine, the majority of patients with STE-ACS can be transported directly to the cardiac invasive centre, bypassing the local hospital. 20 
Study population
We identified all patients presenting with STE-ACS and triaged for acute coronary angiography (CAG) between November 2009 and December 2014 at the Heart Centre, Rigshospitalet, Copenhagen University Hospital. The patients were identified from the Eastern Danish Heart Registry, a clinical registry where all CAG and PCI procedures performed in eastern Denmark are prospectively registered.
All patients were evaluated by the cardiologist on call at the cardiac invasive centre. They were diagnosed with STE-ACS if they presented with symptoms suggestive of myocardial infarction (MI) together with significant ST-elevation in their electrocardiogram, as defined in current guidelines. 14, 15 Only patients admitted within 12 h from symptom onset were included. Patients in cardiogenic shock on presentation as well as patients resuscitated after cardiac arrest were included if STEMI was the suspected cause. If a patient was admitted more than once during the study period, only the first admission was included. We excluded patients who died before the CAG could be performed and patients where it was not technically possible to perform CAG. We also excluded foreign residents as follow-up data were not available for these patients.
Coronary angiography
All patients were examined with acute CAG. The invasive cardiologist performing the CAG procedure estimated the degree of CAD, based on visual assessment of the CAG at the time of intervention. Patients with STE-ACS were divided into three groups depending on the severity of CAD: (i) obstructive CAD, defined as a stenosis > _50% of the coronary artery diameter, (ii) non-obstructive CAD, defined as a stenosis 1-49% of the coronary artery diameter, and (iii) normal coronary arteries, defined as no angiographically visible stenosis or atheromatosis.
Patient characteristics
We collected data on demographic characteristics and medical history, including cardiovascular risk factors, from the Eastern Danish Heart Registry. We also obtained peak levels of troponin T (TnT) from the primary admission (TnT and high-sensitive TnT, Roche diagnosticsV R , Mannheim, Germany) from the Danish Clinical Laboratory Information System Research Database (LABKA). TnT levels above the local diagnostic reference limit, defined by the 99th percentile, were classified as elevated. For all patients without obstructive CAD, we registered the discharge diagnosis from the primary admission.
Survival
We followed all patients from the day of their primary admission until death, emigration, or 15 May 2015, which was the end date of complete follow-up data acquisition. All patients were traced to the end of the follow-up period, except for 22 patients (0.5%) who emigrated during the study period and were only followed until the day of emigration. For all patients who died during the study period, we identified causes of death based on thorough evaluation of medical records. Causes of death were classified by a previously published method as described in Supplementary material online, Table S1 . From the nation-wide registry StatBank Denmark, we obtained age and gender specific mortality data for the Danish general population during 2010-2014. 21 We then estimated the average survival of people in the general population matched to the STE-ACS patients by age and sex in a 20:1 ratio by a previously established method. 22 Finally, survival in STE-ACS patients was compared with survival of people in the general population.
Statistical analysis
Categorical data are expressed as numbers and percentages whereas numerical data are expressed as medians and ranges or inter quartile ranges (IQR for TnT levels in patients with non-obstructive CAD and normal coronary arteries was performed. For the purpose of complete case analysis in the Cox regression analysis, we performed multiple imputation of missing data for independent variables included in the regression model (5.8% in total), using the fully conditional specification method. As mortality in patients with STE-ACS is known to be highest in the initial phase (proportional hazard assumptions are not met), survival analyses were performed as a 30-day landmark analysis. Short-term survival was defined as survival < _30 days and long-term survival as survival >30 days from the day of primary admission. A two-sided P-value < 0.05 was considered statistically significant. Data were analysed using the statistical software IBM SPSS Statistics version 22.0 (SPSS Inc., Chicago, IL, USA).
Ethics
The study complies with the Declaration of Helsinki. The study was approved by the Danish Data Protection Agency (case file no 30-1441) and the Danish National Board of Health (case file no 3-3013-1210/1).
Register-based studies do not require approval from The National Committee on Health Research Ethics according to Danish law.
Results
Baseline characteristics
We included 4793 STE-ACS patients triaged for acute CAG. Of these, 88% (n = 4239) had obstructive CAD, 6% (n = 298) had nonobstructive CAD, and 5% (n = 256) had normal coronary arteries ( Figure 1 ). Baseline patient characteristics are presented in Table 1 .
Patients with normal coronary arteries were younger, more often female, and had a lower prevalence of cardiovascular risk factors compared with patients with obstructive CAD. Patients with nonobstructive CAD presented with a similar cardiovascular risk profile as patients with obstructive CAD.
Discharge diagnoses
Discharge diagnoses for all patients without obstructive CAD are listed in Supplementary material online, Table S2 . A cardiovascular discharge diagnosis was assigned to 81% of patients with nonobstructive CAD and 79% of patients with normal coronary arteries. A non-cardiovascular discharge diagnosis was assigned to 3% of the patients with non-obstructive CAD and 4% of patients with normal coronary arteries. In the remaining patients, the reason for chest pain and ST-elevation was unknown. The most common discharge diagnosis was type 2 MI in patients with non-obstructive CAD (22%) and perimyocarditis in patients with normal coronary arteries (33%).
Survival
A total of 660 patients died during the study period. The median follow-up time was 2.6 years (IQR 1.4-3.6 years). Figure 2 shows survival probabilities and Table 2 shows the hazard of death in patients with and without obstructive CAD.
Survival during the initial 30 days
For both patients with and without obstructive CAD, the risk of death was highest in the initial phase. The crude estimated risk of death within the initial 30 days was 7% [95% confidence interval (CI) 6-8%] for patients with obstructive CAD, 4% (95% CI 2-6%) for patients with non-obstructive CAD, and 2% (95% CI 0.3-3%) for patients with normal coronary arteries. Compared with patients with obstructive CAD, the short-term hazard of death was lower in both patients with nonobstructive CAD [hazard ratio (HR) 0.49, 95% CI 0.27-0.89, P = 0.018] and normal coronary arteries (HR 0.31, 95% CI 0.11-0.83, P = 0.021).
Survival after 30 days
The crude estimated risk of death within 1 year was 10% (95% CI 9-11%) for patients with obstructive CAD, 8% (95% CI 5-11%) for patients with non-obstructive CAD, and 6% (95% CI 3-9%) for patients with normal coronary arteries. The 30-day landmark analysis showed a similar long-term hazard of death in patients with non-obstructive CAD and obstructive CAD. Patients with normal coronary arteries had an increased long-term hazard of death compared with patients with obstructive CAD (HR 2.44, 95% CI 1.58-3.76, P < 0.001).
Survival based on troponin T levels
Of patients with obstructive CAD, 98% had elevated TnT levels and qualified for STEMI criteria. In comparison, 62% of patients with nonobstructive CAD and 54% of patients with normal coronary arteries had elevated TnT levels. When stratifying for TnT levels in patients without obstructive CAD, similar short-and long-term hazards of death were found for patients with normal and elevated TnT ( 
Survival compared with people in the general population
During the initial 30 days, all three subgroups of patients with STE-ACS had a higher hazard of death compared with people in the general population matched on age and sex (P < 0.001 for all three groups) ( Figure 2C-E) . After the initial 30 days, patients with obstructive CAD had a hazard of death similar to people in the general population (HR 1.1, 95% CI 0.99-1.24, P = 0.076). Conversely, the hazard of death was still higher in patients with non-obstructive CAD (HR 1.55, 95% CI 1.06-2.26, P = 0.024) and normal coronary arteries (HR 2.6, 95% CI 1.68-3.87, P < _ 0.001).
Causes of death
Detailed causes of death in STE-ACS patients with and without obstructive CAD are shown in Table 3 and Supplementary material online, Table S3 . For patients who died within the initial 30 days, the cause of death was cardiovascular in 92% with obstructive CAD, 75% with non-obstructive CAD, and 50% with normal coronary arteries.
For patients who died later, the cause of death was cardiovascular in 50, 21, and 29%, respectively. Figure 3 shows the median times to cardiovascular and non-cardiovascular death for the three patient groups.
Discussion
To the best of our knowledge, this is the largest study to date to compare long-term survival and causes of death in STE-ACS patients with and without obstructive CAD. Our main findings were that STE-ACS patients without obstructive CAD (i) had a better short-term survival but similar or worse long-term survival compared with patients with obstructive CAD, (ii) had a worse short-and long-term survival compared with people in the general population, and (iii) mainly died of non-cardiovascular causes of death. Approximately one out of nine patients triaged for acute CAG because of STE-ACS did not have obstructive CAD. Other studies report prevalences ranging between 2 and 29%. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Nearly all patients with obstructive CAD had elevated levels of TnT and thus, qualified for STEMI criteria. This was only true for about half of the patients with non-obstructive CAD and normal coronary arteries. Regardless of whether TnT levels were normal or elevated, patients without obstructive CAD had a similar or increased long-term risk of death compared with patients with obstructive CAD. TnT levels were generally lower in patients without obstructive CAD. The smaller cardiac injury seen in these patients might reflect less severe cardiac disease but also indicate that differential 
diagnoses mimicking STEMI should be considered. Other studies have shown that common underlying conditions other than MI in STE-ACS patients without obstructive CAD are perimyocarditis, coronary artery spasm, and Takotsubo cardiomyopathy. 3, 6, 8, 9, 11, 12, [14] [15] [16] [17] Only a few previous studies have compared survival in STE-ACS patients with and without obstructive CAD and report varying survival rates (Supplementary material online, Table S4) . 2, 3, 5, 8, 10, 11 These studies are all limited by small sample sizes and very low event rates, especially concerning long-term survival where the largest study report no more than three events. This taken together with the fact that the definition of obstructive CAD as well as the follow-up time differed between the studies make any comparisons difficult. For patients with obstructive CAD, we found similar short-and longterm survival probabilities and causes of death as previously reported.
23-25
Clinical perspective STE-ACS patients without obstructive CAD are often considered relatively healthy. Consequently, they receive limited clinical attention and are rapidly discharged from the cardiac invasive centre. It is therefore of concern that in patients with STE-ACS, those with normal coronary arteries were found to have the worst long-term survival. The increased long-term risk of death taken together with the finding that causes of death were more often non-cardiovascular indicate that STE-ACS patients with normal coronary arteries are often at risk of being severely ill, although likely due to conditions other than atherosclerotic CAD. Patients with non-obstructive CAD were more similar to patients with obstructive CAD and therefore more likely to have the same underlying pathology. Cancer was responsible for nearly half of the deaths in patients with normal coronary arteries. This might simply reflect that cancer is the most common cause of death in Denmark. Patients not suffering cardiovascular death are therefore likely to die of cancer. However, cancer with secondary cardiac involvement should be excluded in these patients. Although cardiovascular death was less common in patients with normal coronary arteries, sudden cardiac death was responsible for one-fifth of deaths in this patient group and calls for further investigation.
We suggest that STE-ACS patients without obstructive CAD should be thoroughly examined to diagnose and treat the underlying cause of disease. Cardiac magnetic resonance imaging is the preferred diagnostic tool. 26 The finding that STE-ACS patients without obstructive CAD have lower survival compared with people in the general population with the same age and sex, not only in the initial phase but also in the long term, emphasizes the importance of follow-up in these patients. Large randomized clinical trials are warranted to evaluate secondary prevention and provide evidence for guidelines on how to treat STE-ACS patients without obstructive CAD.
Limitations
Despite a relatively large sample size and almost complete follow-up, this study has some limitations. First, in order to reflect a real-world setting, we included all patients with STE-ACS. It is important to emphasize that this is a heterogeneous group, including both patients who did and did not qualify for STEMI criteria with elevated TnT levels. Thus, our findings do not necessarily reflect the prognosis of an individual patient. Further studies are needed on how to risk stratify STE-ACS patients without obstructive CAD. Second, the degree of CAD was based on visual estimation of the CAG. Visual estimation of CAD is known to be associated with intra-and inter-observer variability. 27 Fractional flow reserve or intravascular imaging techniques, like intravascular ultrasound or optical coherence tomography, would likely increase precision and accuracy. Intravascular imaging could also help detect atherosclerosis located within the coronary artery wall not visible on CAG, known to be present in many patients with angiographically normal coronary arteries. 28 Unfortunately, the use of such techniques in a real-world setting is limited due to cost, procedure time, contrast load, and radiation exposure. Third, patients without obstructive CAD might be less likely to have their death adjudicated as cardiac. Consequently, the frequency of cardiovascular death might be underestimated in these patients. We addressed this by using a pre-defined classification of causes of death. Any death that could not clearly be attributed to a non-cardiac cause was classified as cardiac.
Finally, data on left ventricular ejection fraction and medication were not available. In general, adherence to medical protocol after MI is high in Denmark. 29 Conclusions STE-ACS patients without obstructive CAD had a lower shortterm risk of death compared with patients with obstructive CAD. However, the long-term risk of death was similar in patients with non-obstructive CAD and higher in patients with normal coronary arteries, regardless of TnT levels. Patients with non-obstructive CAD and normal coronary arteries also had a higher short-and long-term risk of death compared with people in the general population. In contrast to patients with obstructive CAD, causes of death in patients without obstructive CAD were mainly non-cardiovascular. Altogether, this suggests that STE-ACS patients without obstructive CAD might benefit from increased medical attention, secondary prevention interventions, and close follow-up.
